Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H P Fell

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Cancer Research|April 15, 1990
Epitope mapping and use of anti-idiotypic antibodies to the L6 monoclonal anticarcinoma antibodyK E Hellström, D E Yelton, H P Fell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1993
Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactionsD M Calderhead, J E Buhlmann, A J van den Eertwegh, et al.
Immunological Reviews|October 1, 1996
Surface expression of CD28 single chain Fv for costimulation by tumor cellsG Winberg, L S Grosmaire, K Klussman, et al.
Advances in Experimental Medicine and Biology|January 1, 1992
Role of contact and soluble factors in the growth and differentiation of B cells by helper T cellsR J Noelle, L Marshall, M Roy, et al.
Biochemical Society Symposium|March 26, 1998
Role of epidermal growth factor receptor family members in growth and differentiation of breast carcinomaB D Cohen, C B Siegall, S Bacus, et al.
Bioconjugate Chemistry|November 5, 1997
Expression and characterization of bryodin 1 and a bryodin 1-based single-chain immunotoxin from tobacco cell cultureJ A Francisco, S L Gawlak, M Miller, et al.
The Journal of Biological Chemistry|August 5, 1992
Chimeric L6 anti-tumor antibody. Genomic construction, expression, and characterization of the antigen binding siteH P Fell, M A Gayle, D Yelton, et al.
Therapeutic Immunology|January 1, 1994
Single-chain mono- and bispecific antibody derivatives with novel biological properties and antitumour activity from a COS cell transient expression systemM S Hayden, P S Linsley, M A Gayle, et al.
Tissue Antigens|October 1, 1996
Costimulation by CD28 sFv expressed on the tumor cell surface or as a soluble bispecific molecule targeted to the L6 carcinoma antigenM S Hayden, L S Grosmaire, N A Norris, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cancer Research|April 15, 1990
Epitope mapping and use of anti-idiotypic antibodies to the L6 monoclonal anticarcinoma antibodyK E Hellström, D E Yelton, H P Fell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1993
Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactionsD M Calderhead, J E Buhlmann, A J van den Eertwegh, et al.
Immunological Reviews|October 1, 1996
Surface expression of CD28 single chain Fv for costimulation by tumor cellsG Winberg, L S Grosmaire, K Klussman, et al.
Advances in Experimental Medicine and Biology|January 1, 1992
Role of contact and soluble factors in the growth and differentiation of B cells by helper T cellsR J Noelle, L Marshall, M Roy, et al.
Biochemical Society Symposium|March 26, 1998
Role of epidermal growth factor receptor family members in growth and differentiation of breast carcinomaB D Cohen, C B Siegall, S Bacus, et al.
Bioconjugate Chemistry|November 5, 1997
Expression and characterization of bryodin 1 and a bryodin 1-based single-chain immunotoxin from tobacco cell cultureJ A Francisco, S L Gawlak, M Miller, et al.
The Journal of Biological Chemistry|August 5, 1992
Chimeric L6 anti-tumor antibody. Genomic construction, expression, and characterization of the antigen binding siteH P Fell, M A Gayle, D Yelton, et al.
Therapeutic Immunology|January 1, 1994
Single-chain mono- and bispecific antibody derivatives with novel biological properties and antitumour activity from a COS cell transient expression systemM S Hayden, P S Linsley, M A Gayle, et al.
Tissue Antigens|October 1, 1996
Costimulation by CD28 sFv expressed on the tumor cell surface or as a soluble bispecific molecule targeted to the L6 carcinoma antigenM S Hayden, L S Grosmaire, N A Norris, et al.
Pageof 3